EXICURE, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
EXICURE, INC. (XCUR) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.70% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2023-03-27
- EXICURE, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 0.70%.
- EXICURE, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 0.00%.
- EXICURE, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was 0.00%.
- EXICURE, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was 0.00%, a 100.00% decline from fiscal 2017.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2022-12-31 | 0.70% 10-K · filed 2023-03-27 |
| 2021-12-31 | 0.00% 10-K · filed 2023-03-27 |
| 2020-12-31 | 0.00% 10-K · filed 2022-03-25 |
| 2018-12-31 | 0.00% 10-K/A · filed 2019-09-23 |
| 2017-12-31 | 0.10% 10-K/A · filed 2019-09-23 |
| 2016-12-31 | 0.00% 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |